SNDL Inkomsten in het verleden

Verleden criteriumcontroles 0/6

SNDL is de winst gegroeid met een gemiddeld jaarlijks percentage van 0.4%, terwijl de Pharmaceuticals industrie de winst jaarlijks groeide met 1.2%. De inkomsten zijn gegroeid met een gemiddelde van 57.2% per jaar.

Belangrijke informatie

0.4%

Groei van de winst

69.5%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie	6.0%
Inkomstengroei	57.2%
Rendement op eigen vermogen	-9.3%
Nettomarge	-12.1%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Analysts Have Made A Financial Statement On SNDL Inc.'s (NASDAQ:SNDL) Third-Quarter Report

Nov 07

Sundial Growers Doubles Revenue With Spiritleaf Acquisition And Reports Positive EBITDA For Q4-2021

Apr 28

Sundial Growers' Cash War Chest And Its Bid To Avoid Another Dilution

Mar 21

Sundial Growers Stock: What To Watch For Going Into 2022

Dec 28

Taking A Look At The Canadian Cannabis Penny Stock: Sundial Growers

Nov 04

Sundial Moves On Alcanna Acquisition And Nova Cannabis Investment

Oct 12

Sundial: A Speculative Buy On The Restructure

Sep 25

Insight Into Sundial Growers' Q2 2021 Earnings Report

Aug 24

Sundial: Can The Recent Acquisition Turn This Story Around?

Jul 23

Evaluating Sundial Growers' Acquisition Of Inner Spirit And Partnership With SAF Group

Jul 01

Sundial Growers regains Nasdaq compliance

Jun 16

Sundial Growers: Finding Ways To Spend That $1.1B Cash

Jun 01

Sundial Growers boosts stake in The Valens Company

May 04

Sundial Growers: The Luckiest Cannabis Stock Of 2021

Feb 04

Cannabis producer Sundial up more than 17% following 14% loss prior day

Feb 03

Sundial Growers trades in red on pricing $74.5M offering

Feb 02

Sundial Growers raises $100M capital through registered offering

Jan 29

Sundial launched premium concentrates products under Top Leaf brand

Jan 12

Sundial Growers: A Busy End To 2020 Indicates Potential Strategic Expansion

Jan 11

After another catalyst, Motley Fool sizes up cannabis sector

Jan 08

Sundial, HEXO lead out big gains in cannabis sector

Jan 06

Seeking Alpha Catalyst Watch

Dec 31

Sundial acquires C$59M special purpose vehicle

Dec 30

Opbrengsten en kosten

Hoe SNDL geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NasdaqCM:SNDL Opbrengsten, kosten en inkomsten (CAD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Sep 24	911	-110	225	0
30 Jun 24	912	-113	224	0
31 Mar 24	916	-136	228	0
31 Dec 23	909	-168	230	0
30 Sep 23	901	-211	221	1
30 Jun 23	894	-287	213	2
31 Mar 23	886	-331	196	2
31 Dec 22	712	-335	158	2
30 Sep 22	495	-266	124	3
30 Jun 22	278	-151	88	2
31 Mar 22	64	-130	60	2
31 Dec 21	56	-227	55	2
30 Sep 21	47	-228	50	2
30 Jun 21	46	-316	49	1
31 Mar 21	57	-296	45	0
31 Dec 20	61	-200	46	0
30 Sep 20	62	-170	59	1
30 Jun 20	77	-184	70	1
31 Mar 20	76	-164	80	3
31 Dec 19	64	-143	86	2
30 Sep 19	49	-156	72	2
30 Jun 19	21	-84	54	2
31 Mar 19	1	-77	37	0
31 Dec 18	0	-68	22	0
28 Feb 18	0	-13	9	0

Kwaliteitswinsten: SNDL is momenteel verliesgevend.

Groeiende winstmarge: SNDL is momenteel verliesgevend.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: SNDL is verlieslatend, maar heeft de verliezen de afgelopen 5 jaar met een snelheid van 0.4% per jaar verminderd.

Versnelling van de groei: Het is niet mogelijk om de winstgroei van SNDL over het afgelopen jaar te vergelijken met het gemiddelde over de afgelopen vijf jaar, omdat het bedrijf momenteel verliesgevend is.

Winst versus industrie: SNDL is verlieslatend, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Pharmaceuticals industrie ( 54.6% ).

Rendement op eigen vermogen

Hoge ROE: SNDL heeft een negatief Return on Equity ( -9.34% ), omdat het momenteel verliesgevend is.

SNDL Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024

SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024

SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)

SNDL Inc. to Report Q1, 2024 Results on May 09, 2024

Recent updates

SNDL Inc. Announces Executive Appointments

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,200,000 shares, representing 5% for CAD 100 million.

Analysts Have Made A Financial Statement On SNDL Inc.'s (NASDAQ:SNDL) Third-Quarter Report

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H).

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC).

SNDL Inc. Appoints J. Carlo to Its Board of Directors

No longer forecast to breakeven

SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million.

SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024

SNDL Inc.'s (NASDAQ:SNDL) Price Is Right But Growth Is Lacking

SNDL Inc., Annual General Meeting, Jul 30, 2024

SNDL: Federal Government Begins Rescheduling Process For Cannabis (Buy)

New major risk - Revenue and earnings growth

SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)

SNDL Inc. to Report Q1, 2024 Results on May 09, 2024

SNDL Inc. (NASDAQ:SNDL) Shares Fly 60% But Investors Aren't Buying For Growth

Consensus EPS estimates upgraded to CA$0.07 loss, revenue downgraded

New minor risk - Share price stability

Full year 2023 earnings: EPS misses analyst expectations

SNDL Inc. to Report Fiscal Year 2023 Results on Mar 21, 2024

SNDL Inc.'s (NASDAQ:SNDL) Revenues Are Not Doing Enough For Some Investors

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.

SNDL Inc. to Report Q3, 2023 Results on Nov 13, 2023

SNDL Inc. Launches New E-Commerce Platform for its Destination Liquor Retail banner, Wine and Beyond

New minor risk - Share price stability

Second quarter 2023 earnings released: CA$0.12 loss per share (vs CA$0.31 loss in 2Q 2022)

SNDL Inc. to Report Q2, 2023 Results on Aug 14, 2023

SNDL Inc.'s (NASDAQ:SNDL) 25% Dip In Price Shows Sentiment Is Matching Earnings

SNDL Inc. Announces Chief Financial Officer Changes

SNDL Inc., Annual General Meeting, Jul 27, 2023

SNDL Inc. to Report Q1, 2023 Results on May 15, 2023

Forecast breakeven date moved forward to 2023

Full year 2022 earnings: Revenues exceed analyst expectations

SNDL Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette.

Forecast breakeven date moved forward to 2023

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS).

Are Investors Undervaluing SNDL Inc. (NASDAQ:SNDL) By 22%?

Now 22% undervalued after recent price drop

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 11,800,000 shares, representing 5% for CAD 100 million.

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

SNDL Inc. to Report Q3, 2022 Results on Nov 14, 2022

SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette.

SNDL Inc. (NasdaqCM:SNDL) entered into an arrangement agreement to acquire remaining 89.9% stake in The Valens Company Inc. (TSX:VLNS) for CAD 92.1 million.

SNDL Starting To Stand Out Among Canadian Cannabis Players

SNDL Inc. to Report Q2, 2022 Results on Aug 12, 2022

Sundial Growers Inc. Announces Resignation of David Gordey as Chief Administrative Officer, Effective July 29, 2022

Sundial Growers whipsaws ahead of shareholder meeting on reverse stock split

Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL).

Sundial Growers Inc. (NasdaqCM:SNDL) entered into a purchase agreement to acquire Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

Sundial Growers Looking Bullish As Revenue Growth From Acquisitions Increases

Sundial Growers Inc. to Report Q1, 2022 Results on May 16, 2022

Sundial Growers Doubles Revenue With Spiritleaf Acquisition And Reports Positive EBITDA For Q4-2021

Sundial Growers Inc., Annual General Meeting, Jun 27, 2022

Sundial Growers Inc. to Report Q4, 2021 Results on Apr 14, 2022